Gabapentin
Product Images NDC 50090-3912

7 FDA label images from A-s Medication Solutions · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 50090-3912). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Gabapentin Tablets (49957454 Bd5a 4d3c 85cf 6fe78aa2c11e 01)

FDA Label Image

Gabapentin Tablets (49957454 Bd5a 4d3c 85cf 6fe78aa2c11e 02)

Gabapentin Tablets (49957454 Bd5a 4d3c 85cf 6fe78aa2c11e 02)
Chemical structure diagram of gabapentin showing cyclohexane ring attached to a carbon linked to an amino (CH2NH2) and a carboxylic acid group (CH2CO2H).*
FDA Label Image

Gabapentin Tablets (49957454 Bd5a 4d3c 85cf 6fe78aa2c11e 03)

Gabapentin Tablets (49957454 Bd5a 4d3c 85cf 6fe78aa2c11e 03)
A line graph comparing mean pain scores over 8 weeks between Gabapentin 3600 mg/day and placebo groups. The x-axis shows time in weeks, divided into a 4-week dose titration period and a 4-week fixed dose period. The y-axis represents mean pain scores from 0 to 10. Gabapentin shows a decrease in pain score over time, while placebo remains relatively stable.*
FDA Label Image

Gabapentin Tablets (49957454 Bd5a 4d3c 85cf 6fe78aa2c11e 04)

Gabapentin Tablets (49957454 Bd5a 4d3c 85cf 6fe78aa2c11e 04)
A line graph depicting the mean pain score over 7 weeks comparing placebo and Gabapentin at dosages of 1800 mg/day and 2400 mg/day. The x-axis is labeled in weeks, from baseline to week 7, and the y-axis shows mean pain score ranging from 0 to 10. The graph includes a 3-week dose titration period followed by a 4-week fixed dose period, showing pain score trends for each group.*
FDA Label Image

Gabapentin Tablets (49957454 Bd5a 4d3c 85cf 6fe78aa2c11e 05)

Gabapentin Tablets (49957454 Bd5a 4d3c 85cf 6fe78aa2c11e 05)
A bar chart comparing percentage values of gabapentin (GBP) versus placebo (PBO) across two studies. Study 1 shows 12% for PBO and 29% for GBP 3600. Study 2 shows 14% for PBO, 32% for GBP 1800, and 34% for GBP 2400. Statistical significance is noted with p-values less than 0.01 and 0.001 in the figure.*
FDA Label Image

Gabapentin Tablets (49957454 Bd5a 4d3c 85cf 6fe78aa2c11e 06)

Gabapentin Tablets (49957454 Bd5a 4d3c 85cf 6fe78aa2c11e 06)
A scatter plot displaying percentage difference versus daily dose in mg for Gabapentin across three studies labeled a, b, and c. The x-axis ranges from 600 to 1800 mg, and the y-axis from 2% to 22% difference. Different symbols represent results from each study at varying doses.*
FDA Label Image

Label Image (Lbl500903912)

Label Image (Lbl500903912)
Gabapentin 800 mg tablet carton label from A-S Medication Solutions. The label indicates a package containing 60 tablets. Storage instructions specify to keep the product at 68 to 77 degrees Fahrenheit. The label also includes a lot number, NDC 50090-3912, and a QR code for dosage information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.